Literature DB >> 19893985

Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.

F B A Makdissi1, L V S T Machado, A G C Oliveira, T T Benvenuti, M L H Katayama, M M Brentani, C A B T Osório, M Mourão Netto, E C Lyra, F Carvalho, J C S Góes, M A A K Folgueira.   

Abstract

Epithelial intercellular cohesion, mainly mediated by E-cadherin (CDH1) expression and function, may be deregulated during cancer cell invasion of adjacent tissues and lymphatic and vascular channels. CDH1 expression is down-modulated in invasive lobular breast carcinomas but its regulation in invasive ductal carcinomas (IDC) is less clear. CDH1 expression is repressed by transcription factors such as Snail (SNAI1) and its product is degraded after Hakai ubiquitination. We compared CDH1, SNAI1 and HAKAI mRNA expression in IDC and paired adjacent normal breast tissue and evaluated its relation with node metastasis and circulating tumor cells. Matched tumor/peritumoral and blood samples were collected from 30 patients with early IDC. Epithelial cells from each compartment (tumor/peritumoral) were recovered by an immunomagnetic method and gene expression was determined by real time RT-PCR. There were no differences in CDH1, SNAI1 and HAKAI mRNA expression between tumor and corresponding peritumoral samples and no differential tumoral gene expression according to nodal involvement. Another 30 patients with a long-term follow-up (at least 5 years) and a differential prognosis (good or poor, as defined by breast cancer death) had E-cadherin and Snail protein detected by immunohistochemistry in tumor samples. In this group, E-cadherin-positive expression, but not Snail, may be associated with a better prognosis. This is the first report simultaneously analyzing CDH1, SNAI1 and HAKAI mRNA expression in matched tumor and peritumoral samples from patients with IDC. However, no clear pattern of their expression could distinguish the invasive tumor compartment from its adjacent normal tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893985     DOI: 10.1590/s0100-879x2009001200002

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  10 in total

1.  The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.

Authors:  Dabei Tang; Shanqi Xu; Qingyuan Zhang; Wenhui Zhao
Journal:  Med Oncol       Date:  2011-04-26       Impact factor: 3.064

2.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

Authors:  Edward H Cho; Marco Wendel; Madelyn Luttgen; Craig Yoshioka; Dena Marrinucci; Daniel Lazar; Ethan Schram; Jorge Nieva; Lyudmila Bazhenova; Alison Morgan; Andrew H Ko; W Michael Korn; Anand Kolatkar; Kelly Bethel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

Review 3.  Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation:a systematic review and meta-analysis.

Authors:  W Zhu; L Xing; J Yue; X Sun; X Sun; H Zhao; J Yu
Journal:  Br J Radiol       Date:  2012-02-14       Impact factor: 3.039

4.  N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors.

Authors:  Florent Péglion; Sandrine Etienne-Manneville
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

5.  Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.

Authors:  Solange Torchia Carvalho; Monica Maria Stiepcich; José Humberto Fregnani; Sueli Nonogaki; Rafael Rocha; Fernando Augusto Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detection.

Authors:  Yu Tao; Mingqiang Li; Bumjun Kim; Debra T Auguste
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

7.  Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer.

Authors:  Fangchao Zheng; Feng Du; Haili Qian; Jiuda Zhao; Xue Wang; Jian Yue; Nanlin Hu; Yiran Si; Binghe Xu; Peng Yuan
Journal:  Biomark Res       Date:  2021-04-29

8.  Classification and immune invasion analysis of breast cancer based on m6A genes.

Authors:  Qiang Qin; Da Lang Fang; Weijie Zhou; Yuhua Meng; Jie Wei
Journal:  Ann Transl Med       Date:  2021-09

9.  E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors.

Authors:  Eike Burandt; Felix Lübbersmeyer; Natalia Gorbokon; Franziska Büscheck; Andreas M Luebke; Anne Menz; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Frank Jacobsen; Patrick Lebok; Till Sebastian Clauditz; Guido Sauter; Ronald Simon; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Sarah Minner; Rainer Krech; David Dum; Till Krech; Andreas Holger Marx; Christian Bernreuther
Journal:  Biomark Res       Date:  2021-06-05

Review 10.  The emerging role of RNA N6-methyladenosine methylation in breast cancer.

Authors:  Fangchao Zheng; Feng Du; Jiuda Zhao; Xue Wang; Yiran Si; Peng Jin; Haili Qian; Binghe Xu; Peng Yuan
Journal:  Biomark Res       Date:  2021-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.